glp 1 agonist pcos GLP-1s Lead to Greater Weight Loss and A1C Improvement Than Metformin in Patients with GLP-1 receptor agonists & PCOS:

This aligns with human studies linking high cysteine levels to obesity, neurological disorders and cardiovascular diseases 55,56,57,58,59

Essential Extras: An additional violation noted in the Form 483 FDA inspection report but corrected before the warning letter was issued was for vermin infestation due to the observation of a live spider in the production area and a dead cricket in the middle of the incubator room. Telehealth company Hims & Hers acquired MedisourceRx in September 2024, allowing it to bring much of its drug compounding operations in-house

Crucially, Crat knockout experiments partially reversed these metabolic improvements, establishing CrAT-mediated SREBP1c inhibition as a key mechanism through which L-carnitine counteracts de novo lipogenesis

Patients who cannot tolerate GLP-1 side effects and want a body composition intervention without appetite suppression are also well matched to tesamorelin